19 December 2025
The Millbrook Healthcare group has today published its financial statements for the year to 30 June 2025. The consolidated financial statements are available here.
Tim Jones, Group Finance Director, said:
“We are very pleased to publish these results today, which show the continued strengthening of the group.
There has been great success during the year in gaining new, renewed and extended contracts across the business. This success has continued since the year end with many additional new contracts secured, which will see a material growth for the group in the coming year.
Turnover for the year was £114m, which comprises CES of £90m and a growth in other business lines to £24m.
The EBITDA reported of £3.8m represents good growth from the prior year (2024: £2.5m). We anticipate increased trading demand and strong growth in EBITDA for the forthcoming year.
Cash interest costs were £524k (2024: £660k). Our bank debt to EBITDA ratio is 2.0 times, which is well below industry norms and demonstrates the financial security of the group. In addition to cash balances, the group has finance facilities in place to fund growth and working capital requirements with £3.0m available as at 30 June 2025.”
Key financial points include:
- Revenue of £114m.
- EBITDA profit of £3.8m.
- Cash generated from operating activities of £1.6m.
- The Group has positive net current assets of £3.6m and excluding the shareholder loan notes has over £17m of net assets.
- The financial statements show net debt of just £7.3m to third parties (ie excluding shareholders) which principally comprises a low-risk invoice discounting facility.
- We have loan notes that are owed to the shareholders; this is an investment by our shareholders, and they would never ask for any of it to be repaid unless the company could afford it, interest is not cash settled but deferred. These loan notes should therefore not be seen as a liability that affects the day-to-day trading or cash position of the business. Since the year end, our shareholders have shown their commitment to the continued growth of the business and extended the maturity of £41.9m of loan notes until July 2028.
Notes on the financial statements
The company at the top of the ownership structure is Millbrook Healthcare Holdings Limited and the accounts for this company show the consolidated numbers for the whole of the Millbrook Healthcare group.
Millbrook Healthcare Limited, Ultimate Healthcare Limited and Livity Life Limited were the main trading subsidiary companies.
The accounts of the various companies will be available on the Companies House website in the coming days:
Millbrook Healthcare Holdings Limited
Millbrook Healthcare Limited
Ultimate Healthcare Limited
Livity Life Limited
